2. Academic Validation
  3. GSNO induced mitochondrial Cx43 nitrosylation in cardiomyocyte differentiation from mouse ES cells in vitro

GSNO induced mitochondrial Cx43 nitrosylation in cardiomyocyte differentiation from mouse ES cells in vitro

  • Biochem Pharmacol. 2025 Jul:237:116955. doi: 10.1016/j.bcp.2025.116955.
Jiayu Qi 1,  Ying Shao 2,  Liting Chen 1,  Danyan Zhu 3
Affiliations

Affiliations

  • 1 Institute of Pharmacology and Toxicology, College of Pharmaceutical Sciences, Zhejiang Key Laboratory of Neuropsychopharmacology, Zhejiang University, Hangzhou 310058, China.
  • 2 Institute of Pharmacology and Toxicology, College of Pharmaceutical Sciences, Zhejiang Key Laboratory of Neuropsychopharmacology, Zhejiang University, Hangzhou 310058, China; The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China.
  • 3 Institute of Pharmacology and Toxicology, College of Pharmaceutical Sciences, Zhejiang Key Laboratory of Neuropsychopharmacology, Zhejiang University, Hangzhou 310058, China. Electronic address: zdyzxb@zju.edu.cn.
PMID: 40280246 DOI: 10.1016/j.bcp.2025.116955
Abstract

S-nitrosoglutathione (GSNO), considered vital to S-nitrosylation of proteins, has been found fundamentally important to the cardiomyocytes (CMs) maturation. Our previous studies demonstrated that GSNO treatment significantly enhanced the S-nitrosylation of 104 proteins during the differentiation of mouse embryonic stem cells (ESCs) into CMs. Mitochondrial Cx43 (mtCx43), a membrane protein implicated in the intercellular communication, also plays a pivotal role in CMs regeneration from stem cells. However, the involvement of mtCx43 S-nitrosylation in GSNO-induced myocardial differentiation has not been fully elucidated. In this study, we employed an ESCs-derived CMs differentiation model to elucidate the mechanisms underlying GSNO-induced cardiogenesis. Our findings revealed that GSNO treatment significantly up-regulated mitochondrial transmembrane potential, ATP production, Reactive Oxygen Species (ROS) levels, respiratory chain complex Ι activity and mtCx43 hemichannel permeability in embryoid bodies (EBs). Furthermore, S-nitrosylation of mtCx43 was markedly enhanced in differentiating EBs after GSNO treatment. Overexpression of mtCx43 further amplified the pro-mitochondrial maturation effects of GSNO, whereas overexpression of a mutant form, mtCx43C271A attenuated this effect. To investigate the functional role of mtCx43 hemichannels, we pretreated EBs with Gap19, a specific mtCx43 hemichannel blocker, followed by GSNO administration. Gap19 significantly reduced in mitofusin 2 (Mfn2) expression, thereby impairing mitochondrial maturation and function. In addition, Gap19 treatment abrogated the pro-cardiogenic effects of mtCx43 S-nitrosylation. Furthermore, we demonstrated that mtCx43 S-nitrosylation-induced cardiac differentiation was dependent on mitochondrial CA2+ uptake. In conclusion, GSNO-induced S-nitrosylation of mtCx43 enhances mitochondrial function in EBs by promoting the opening of mtCx43 hemichannels, thus facilitating the targeted differentiation of ESCs into CMs. These findings provide novel insights into the role of mtCx43 S-nitrosylation in mitochondrial regulation and cardiac lineage commitment.

Keywords

Cardiomyocytes; Embryonic stem cells; Mitochondrial connexin 43; S-Nitrosoglutathione; S-Nitrosylation.

Figures
Products
嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z